Abstract
The present study was aimed to determine the effect of iron supplementation on levels of soluble intercellular adhesion molecule-1 (sICAM-1) and soluble vascular cell adhesion molecule-1 (sVCAM-1) in patients with iron deficiency anemia (IDA). In this study, 26 female patients diagnosed with iron deficiency were treated approximately 3 months of oral iron supplementation (99 ± 10 days; ferrous glycine sulfate; 100 mg/day of elemental iron). Levels of sICAM-1 and sVCAM-1 were assessed prior to treatment and after approximately 3 months of treatment and compared with 26 healthy female subjects. A significant increase in sVCAM levels was found in the patients with iron deficiency at the end of the treatment relative to pretreatment levels compared to controls, whereas no significant differences were determined in sICAM levels. In the posttreatment period, no significant change was observed in sICAM levels compared to the pretreatment levels, whereas sVCAM levels decreased. However, after the treatment period, the sVCAM, hemoglobin, mean corpuscular volume (MCV), and serum ferritin levels did not return to the normal range compared to the controls. Pretreatment sVCAM-1 levels were inversely correlated with levels of hemoglobin, hemotocrit, MCV, serum iron, and ferritin. After treatment, the sVCAM-1 levels were negatively correlated with ferritin levels. Levels of sVCAM were significantly higher in patients with IDA than controls. After the treatment period, the sVCAM levels were not completely normalized in patients with IDA compared to controls, regardless of the presence of inadequate levels of hemoglobin, MCV, and serum ferritin. Thus, iron supplementation not only ameliorates anemia, but may also reduce the inflammation markers in cases with IDA.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Akins PT, Glenn S, Nemeth PM, Derdeyn CP (1996) Carotid artery thrombus associated with severe iron deficiency anemia and thrombocytosis. Stroke 27:1002–1005
Aoki N, Sakai T (1989) Cerebral sinus thrombosis in patients with severe iron deficiency anemia due to myoma uteri. Acta Neurochir (Wien) 97:131–134
Hartfield DS, Lowry NJ, Keene DL, Yager JY (1997) Iron deficiency: a cause of stroke in infants and children. Pediatr Neurol 16:50–53
Rockey DC, Cello JP (1993) Evaluation of the gastrointestinal tract in patients with iron deficiency anemia. N Engl J Med 329:1691–1695
Lapenna D, de Gioia S, Ciofani G, Mezzetti A, Ucchino S, Calafiore AM, Napolitano AM, Di Ilio C, Cuccurullo F (1998) Glutathione-related antioxidant defenses in human atherosclerotic plaques. Circulation 19;97(19):1930–1934
Aslan M, Kosecik M, Horoz M, Selek S, Celik H, Erel O (2007) Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia. Atherosclerosis 191(2):397–402
Davies MJ, Gordon JL, Gearing AJ, Pigott R, Woolf N, Katz D et al (1993) The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 171:223–229
O’Brien KD, Allen MD, McDonald TO, Chait A, Harlan JM, Fishbein D et al (1993) Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 92:945–951
O’Brien KD, McDonald TO, Chait A, Allen MD, Alpers CE (1996) Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 93:672–682
Turhan H, Saydam GS, Erbay AR, Ayaz S, Yasar AS, Aksoy Y, Basar N, Yetkin E (2006) Increased plasma soluble adhesion molecules; ICAM-1, VCAM-1, and E-selectin levels in patients with slow coronary flow. Int J Cardiol 108:224–230
De Caterina R, Basta G, Lazzerini G, Dell’Omo G, Petrucci R, Morale M et al (1997) Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterioscler Thromb Vasc Biol 17:2646–2654
Stenvinkel P (2003) Anaemia and inflammation: what are the implications for the nephrologist? Nephrol Dial Transplant Suppl 8:17–22
Collins AJ, Ma JZ, Xia A, Ebben J (1998) Trends in anemia treatment with erythropoietin usage and patient outcomes. Am J Kidney Dis 32(6 Suppl 4):S133–S141
Drexler H (1999) Nitric oxide and coronary endothelial dysfunction in humans. Cardiovasc Res 43:572–579
Semaan HB, Gurbel PA, Anderson JL, Muhlestein JB, Carlquist JF, Horne BD, Serebruany VL (2000) Soluble VCAM-1 and E-selectin, but not ICAM-1 discriminate endothelial injury in patients with documented coronary artery disease. Cardiology 93(1–2):7–10
Braun M et al (1999) Cellular adhesion molecules on vascular smooth muscle cells. Cardiovasc Res 41:395–401
Frijns CJM, Kappelle LJ (2002) Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke 33:2115–2122
Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, Davis V, Gutierrez-Ramos JC, Connelly PW, Milstone DS (2001) A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 107(10):1255–1262
Iiyama K, Hajra L, Iiyama M, Li H, DiChiara M, Medoff BD, Cybulsky MI (1999) Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ Res 85:199–207
Disclosures
There are no conflicts of interest. The authors are responsible for the content and writing of the paper.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yuksel, A., Kebapcilar, L., Erdur, E. et al. The Effect of Iron Treatment on Adhesion Molecules in Patients with Iron Deficiency Anemia. Biol Trace Elem Res 137, 317–323 (2010). https://doi.org/10.1007/s12011-009-8585-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-009-8585-5